Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

American Healthcare REIT (AHR) Share-based Compensation (2016 - 2025)

American Healthcare REIT (AHR) has disclosed Share-based Compensation for 10 consecutive years, with $5.5 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Share-based Compensation rose 167.6% year-over-year to $5.5 million, compared with a TTM value of $14.6 million through Dec 2025, up 48.14%, and an annual FY2025 reading of $14.6 million, up 48.14% over the prior year.
  • Share-based Compensation was $5.5 million for Q4 2025 at American Healthcare REIT, up from $3.4 million in the prior quarter.
  • Across five years, Share-based Compensation topped out at $9.6 million in Q4 2021 and bottomed at -$14000.0 in Q1 2021.
  • Average Share-based Compensation over 5 years is $2.2 million, with a median of $1.6 million recorded in 2023.
  • The sharpest move saw Share-based Compensation plummeted 132.56% in 2021, then skyrocketed 6661.54% in 2022.
  • Year by year, Share-based Compensation stood at $9.6 million in 2021, then tumbled by 86.98% to $1.3 million in 2022, then dropped by 1.44% to $1.2 million in 2023, then skyrocketed by 65.21% to $2.0 million in 2024, then soared by 167.6% to $5.5 million in 2025.
  • Business Quant data shows Share-based Compensation for AHR at $5.5 million in Q4 2025, $3.4 million in Q3 2025, and $3.2 million in Q2 2025.